Stockscreener 앱 받기
173.97
0.42%
0.72
Guardant Health Inc 주식(GH)의 최신 뉴스
Form 4 Guardant Health Inc: Roberto Mignone (Director) For: 21 October - Investing.com Nigeria
Natera Partners With TransCode to Advance Colorectal Cancer Trial - Zacks Investment Research
Guardant Health director Tariq Musa sells $19,242 in stock By Investing.com - Investing.com South Africa
Form 4 Guardant Health Inc: Medina Manuel Hidalgo (Director) For: 17 October - Investing.com Nigeria
Form 4 Guardant Health Inc: Medina Manuel Hidalgo (Director) For: 17 October - Investing.com Canada
Guardant Health director Tariq Musa sells $19,242 in stock - Investing.com
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? - Zacks Investment Research
Director Tariq Musa proposes selling 116 Guardant Health (GH) shares. - Stock Titan
Guardant Health director Alex M. Azar II sells $11,032 in stock By Investing.com - Investing.com South Africa
Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 14 October By Investing.com - Investing.com South Africa
Guardant Health director Alex M. Azar II sells $11,032 in stock - Investing.com
Guardant Health director Alex M. Azar II sells $11,032 in stock - Investing.com Canada
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Zacks Investment Research
A director proposes selling 69 Guardant Health (GH) shares valued at $11,032. - Stock Titan
Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 12 October - Investing.com Canada
Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 12 October - Investing.com Nigeria
Form 4 Guardant Health Inc: Helmy Eltoukhy (Director, Co-Chief Executive Officer) For: 30 September - Investing.com Canada
Form 4 Guardant Health Inc: Helmy Eltoukhy (Director, Co-Chief Executive Officer) For: 30 September - Investing.com Nigeria
Julia Letlow Stock Trades and Disclosures - TechGraph
Form 4 Guardant Health Inc For: 22 September By Investing.com - Investing.com Canada
Form 4 Guardant Health Inc For: 22 September By Investing.com - Investing.com Nigeria
Form 4 Guardant Health Inc For: 22 September By Investing.com - Investing.com UK
Director Steve Krognes Sells 6,674 Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health (GH) director plans new stock sale - Stock Titan
Guardant Health (NASDAQ: GH) director may sell $144K in equity-comp stock - Stock Titan
Guardant Health (NASDAQ: GH) director moves to sell 6,674 shares - Stock Titan
Officer at Guardant Health (NASDAQ: GH) plans sale of 7,738 shares under Rule 144 - Stock Titan
Guardant Health CIO Kumud Kalia sells $632k in stock - Investing.com
Guardant Health Inc Share PriceGH, RNS News, Articles, Quotes, & Charts - Proactive financial news
Guardant Health (NASDAQ: GH) officer moves to sell more stock - Stock Titan
(GH) Volatility Zones as Tactical Triggers - Stock Traders Daily
Bernstein reiterates Guardant Health stock rating on margin outlook - Investing.com
Bernstein reiterates Guardant Health stock rating on margin outlook By Investing.com - Investing.com Canada
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer - BioSpace
GH Maintained by UBS -- Price Target Raised to $225 - GuruFocus
Guardant Health and Collaborators Present 20 Abstracts Showcasing Advances in Liquid Biopsy Tests and Methylation-Based Tumor Classification for Lung Cancer At 2026 World Conference on Lung Cancer - marketscreener.com
GH Initiates Coverage On Guardant Health -- Buy Rating by Rothsc - GuruFocus
Business Insider Names Guardant Health One of America's Most Innovative Businesses - Business Wire
GH Initiates Coverage On Guardant Health -- Buy Rating by Rothsc - GuruFocus
What Makes Guardant Health (GH) a Compelling Bet? - Yahoo Finance
Rothschild Redburn initiates Guardant Health stock with buy rating By Investing.com - Investing.com Canada
Rothschild Redburn initiates Guardant Health stock with buy rating By Investing.com - Investing.com India
Rothschild Redburn initiates Guardant Health stock with buy rating - investing.com
Rothschild Redburn initiates Guardant Health stock with buy rating - Investing.com
AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah - Zacks Investment Research
Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 20% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Guardant Health Leads the Way in Blood-Based Single Cancer Screening - Morningstar
Guardant Health Stock Price Forecast. Should You Buy GH? - StockInvest.us
GH Looks 144.6% Overvalued on GF Value™ - GuruFocus
Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection - Yahoo Finance
0.75%
0.04%
자본화:
|
볼륨(24시간):